Purple Biotech Ltd. (PPBT)

Purple Biotech Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Purple Biotech Ltd. (PPBT) is a Biotechnology company based in IL with a market capitalization of $191.9K. Free cash flow was negative at -$5.5M. This page tracks PPBT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IL · 9 employees · IPO Nov 20, 2015

Valuation

Valuation & price

$3.94as of May 17, 2026· -85.0% vs 52w high

P/E ratio

Latest-FY diluted EPS

0.02

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$26.20$13.83$1.46Jul 25Jan 26Jul 26
$1.4152-week range$26.20
Loading valuation history…

Fundamentals

Key fundamentals

$191.9K

Market cap

Revenue growth (YoY)

-0.1%

Gross margin

-$5.5M

Free cash flow (USD)

-$9.3M

Net debt

Net cash position

-98.5%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20162025

$0$0

Free cash flow by year

20162025

-$6.3M-$5.5M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-0.09)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingJun 23, 2026Filing

    Corporate Presentation

  • 6-K filingJun 11, 2026Filing

    Preclinical Data Presentation

  • Annual reportMay 15, 2026Filing

    Annual Report Filed

  • 6-K filingApr 27, 2026Filing

    New Data Announcement

  • 6-K filingApr 23, 2026Filing

    Scientific Advisory Board Established

Questions

Frequently asked questions

What is Purple Biotech Ltd.'s market cap?

Purple Biotech Ltd. (PPBT) has a market capitalization of $191.9K.

What is PPBT's P/E ratio?

A meaningful P/E ratio is not available for PPBT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is PPBT's price-to-book (P/B) ratio?

PPBT trades at 0.02 times book value per share.

When did Purple Biotech Ltd. last report earnings?

PPBT last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying PPBT stock?

SEC Form 4 filings show no open-market insider buys at Purple Biotech Ltd. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.